P3 Health Partners (PIII) Stock Price, News & Analysis

Company Overview

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics. By combining proprietary software with professional services teams, P3 Health Partners assists payers in identifying gaps in care, enhancing member engagement and ensuring compliance with state and federal guidelines. Its solutions encompass data ingestion, normalization, predictive modeling and targeted outreach strategies designed to drive measurable improvements in clinical and financial outcomes.

Headquartered in Dallas, Texas, P3 Health Partners serves a broad base of commercial, Medicare Advantage and Medicaid health plans across the United States. The company is led by a management team with deep expertise in healthcare analytics, payer operations and quality improvement initiatives. Through strategic partnerships and ongoing investment in its technology platform, P3 Health Partners aims to help clients navigate the evolving healthcare landscape and deliver more cost-effective, member-centric care.

Key Stats

• Today's Range: $10.45 to $11.75
• 50-Day Range: $2.36 to $16.47
• 52-Week Range: $1.52 to $16.89
• Volume: 69,841 shs
• Average Volume: 3.93 million shs
• Market Capitalization: $83.84 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $14.00
• Consensus Rating: Hold

P3 Health Partners Stock Analysis - MarketRank™

P3 Health Partners scored higher than 32% of companies evaluated by MarketBeat, and ranked 632nd out of 865 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Hold

Consensus Rating

P3 Health Partners has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and 1 sell rating.

Upside Potential

P3 Health Partners has a consensus price target of $14.00, representing about 20.9% upside from its current price of $11.58.

Amount of Analyst Coverage

P3 Health Partners has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of P3 Health Partners is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of P3 Health Partners is -0.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.78% of the float of P3 Health Partners has been sold short.

Short Interest Ratio / Days to Cover

P3 Health Partners has a short interest ratio ("days to cover") of 0.05, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in P3 Health Partners has recently increased by 293.29%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

P3 Health Partners does not currently pay a dividend.

Dividend Growth

P3 Health Partners does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for P3 Health Partners this week, compared to 1 article on an average week.

Search Interest

17 people have searched for PIII on MarketBeat in the last 30 days. This is an increase of 240% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, P3 Health Partners insiders have not sold or bought any company stock.

Percentage Held by Insiders

17.79% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

7.75% of the stock of P3 Health Partners is held by institutions.

Company Calendar

• Last Earnings: 5/14/2026
• Today: 6/05/2026
• Next Earnings (Estimated): 8/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:PIII
• CIK: 1832511
• Web: foresightacq.com
• Phone: 702-910-3950
• Fax: N/A
• Employees: 500
• Year Founded: N/A

Price Target and Rating

• Average Price Target for P3 Health Partners: $14.00
• High Price Target: $14.00
• Low Price Target: $14.00
• Potential Upside/Downside: +20.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($38.60)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$147.95 million
• Net Margins: -8.57%
• Pretax Margin: -19.42%
• Return on Equity: -302.33%
• Return on Assets: -19.99%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.33
• Quick Ratio: 0.33

Sales & Book Value

• Annual Sales: $1.46 billion
• Price / Sales: 0.06
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($21.55) per share
• Price / Book: -0.54

Miscellaneous

• Outstanding Shares: 7,240,000
• Free Float: 5,956,000
• Market Cap: $83.84 million
• Optionable: Not Optionable
• Beta: 1.60